Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
531.4 USD | +1.19% | +6.82% | +12.69% |
Apr. 19 | UBS Adjusts Price Target on Elevance Health to $605 From $585, Maintains Buy Rating | MT |
Apr. 19 | Bernstein Adjusts Price Target on Elevance Health to $665 From $629 | MT |
Official Publications
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 10Q-1 | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 10K | CO | |
SEC Filing 13G | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
3rd quarter results | CO | |
SEC Filing 10Q-3 | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO |
- Stock Market
- Equities
- ELV Stock
- News Elevance Health, Inc.
- Official Publications